1,25 (OH)2D3 treatment alters the granulomatous response in M. tuberculosis infected mice (original) (raw)

Identification and Validation of Novel Drug Targets in Tuberculosis

Vinayak Singh

Current Pharmaceutical Design, 2004

View PDFchevron_right

Bedside inflammatory mediators in pulmonary tuberculosis

Shereen Gad

Egyptian Journal of Bronchology, 2017

View PDFchevron_right

Tuberculosis and nutrition

Suman Vishvkarma

Lung India, 2009

View PDFchevron_right

Recent Trends in Treatment of Multidrug Resistant-Tuberculosis-A Review

hari prasath

Mycobacterial Diseases, 2017

View PDFchevron_right

Caprine tuberculosis eradication program: an immunohistochemical study

David Villar Argaiz

Small Ruminant Research, 2002

View PDFchevron_right

The joint Médecins Sans Frontières/Ministry of Health multidrug-resistant tuberculosis

Dilrabo ulmasova

2016

View PDFchevron_right

New regimens for reducing the duration of treatment of drug-susceptible pulmonary tuberculosis

Marcus Conde

Drug Development Research, 2011

View PDFchevron_right

The Medical Research Council and treatments for tuberculosis before streptomycin

Linda Bryder

Journal of the Royal Society of Medicine, 2014

View PDFchevron_right

A multilevel analysis of tuberculosisassociated factors

Maria Lucia F Penna

Revista de Salud Pública, 2009

View PDFchevron_right

Functional and Phenotypic Changes In Monocytes From Patients With Tuberculosis Are Reversed With Treatment

MARIA JESUS TORQUEMADA SANCHEZ

Microbes and …, 2006

View PDFchevron_right

Treatment of Latent Tuberculosis Infection in Patients Aged ≥35 Years

Andrea Cruz

Clinical Infectious Diseases, 2000

View PDFchevron_right

Tuberculosis and HIV: Renewed Challenge

Marcus Conde

Memórias do Instituto Oswaldo Cruz, 1998

View PDFchevron_right

Guidelines for the management of drug-resistant tuberculosis

Jacques Grosset

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1998

View PDFchevron_right

An unexpected case of disseminated tuberculosis from tumour necrosis factor inhibition

Robert Macginley

2020

View PDFchevron_right

Tuberculosis Is Associated with a Down-Modulatory Lung Immune Response That Impairs Th1-Type Immunity

Neio Boéchat

The Journal of Immunology, 2009

View PDFchevron_right

World Health Organization Group 5 Drugs for the Treatment of Drug-Resistant Tuberculosis: Unclear Efficacy or Untapped Potential?

Ekwaro OBUKU

Journal of Infectious Diseases, 2012

View PDFchevron_right

Old Drugs, New Purpose: Retooling Existing Drugs for Optimized Treatment of Resistant Tuberculosis

Ekwaro OBUKU

Clinical Infectious Diseases, 2012

View PDFchevron_right

The return of tuberculosis

Richard Wenzel

Diagnostic Microbiology and Infectious Disease, 1999

View PDFchevron_right

Nasal Ulceration Reveling Multifunctional Tuberculosis

Djibril Samaké

Experiments in Rhinology & Otolaryngology, 2020

View PDFchevron_right

Tuberculosis; Relapse in Interrupted Antituberculous Therapy

Muhammad Abdur Rehman khadam, Awais Iqbal

THE PROFESSIONAL MEDICAL JOURNAL, 2017

View PDFchevron_right

Effect of Antituberculosis Treatment on Serum Zinc Level in Tuberculosis

Zunjarrao Z Badade, Youb Neupane

Journal of Universal College of Medical Sciences, 2013

View PDFchevron_right

Variability in Tuberculosis Granuloma T Cell Responses Exists, but a Balance of Pro- and Anti-inflammatory Cytokines Is Associated with Sterilization

Joanne Flynn

PLOS Pathogens, 2015

View PDFchevron_right

Latent Tuberculosis: Advances in Diagnosis and Treatment

Georgia Vrioni

Pulmonary Infection, 2012

View PDFchevron_right

T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment

Tom h.m. Ottenhoff

Diagnostic Microbiology and Infectious Disease, 2009

View PDFchevron_right

Bone and Joint Tuberculosis

Prakash Sitoula

AJN, American Journal of Nursing, 1948

View PDFchevron_right